ELII: Bioavailable proteasome inhibitors as broad-spectrum antivirals

Project: Research project

Project Details

StatusFinished
Effective start/end date7/1/14 → 6/30/19

Funding

  • National Institute of Allergy and Infectious Diseases ( Award #5R33AI10226705): $1,240,966.00